MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202541123843 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Dec. 9, 2025, for 'study of copper ferrite (cufe2o4) nanoparticles as mri contrast agents for brain tumour imaging.'

Inventor(s) include Dr. Anitta Xavier A; Dr. P Vijayalakshml; Dr. Muthiah; and Deepak Nallaswamy Veeraiyan.

The application for the patent was published on Feb. 13, under issue no. 07/2026.

According to the abstract released by the Intellectual Property India: "A novel MRI contrast agent composition comprising copper ferrite (CuFe2O4) nanoparticles and methods of use for enhanced detection and imaging of brain tumors. The CuFe204 nanoparticles exhibit superparamagnetic behavior leading to local T2 shortening and improved contrast on T2-weighted MRJ. The nanoparticles are surface-functionalized for, blood-brain-barrier penetration and tumor targeting, demonstrate favorable biocompatibility and biodistribution in animal models, and provide potential theranostic.capabilities through catalytic and magnetic properties. The invention covers compositions, methods of synthesis, functionalization, administration protocols, imaging methods, and kits for clinical and preclinical neuro-oncological imaging. A novel MRI contrast agent composition comprising copper ferrite (CuFe204) nanoparticles and methods of use for enhanced detection and imaging of brain tumors. The CuFe2O4 nanoparticles exhibit superparamagnetic behavior leading to local T2 shortening and improved contrast on T2-weighted MRI, The nanoparticles are surface-functionalized for blood-brain-barrier penetration and tumor targeting, demonstrate favorable biocompatibility and biodistribution in animal models, and provide potential theranostic capabilities through catalytic and magnetic properties. The invention covers compositions, methods of synthesis, functionalization, administration protocols, imaging methods, and kits for clinical and preclinical neuro-oncological imaging."

Disclaimer: Curated by HT Syndication.